Position in ZTS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$233,380,104
+$27,702,407 QoQ
Shares Held
1,974,284
+20.8% QoQ
Ownership
0.471%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 98.8568007439659.ToString("F0")%
Shared 0.4773376069501652.ToString("F0")%
None 0.6658616490839211.ToString("F0")%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Derivatives in ZTS
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$12,045,599
PutShares
101,900
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ROYAL BANK OF CANADA holds $672,203,105 across 64 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (34.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
1,974,284 | $233,380,104 | |
| 2 | RDY |
Dr Reddys Laboratories Ltd
|
9,984,082 | $138,279,533 | |
| 3 | BHC |
Bausch Health Companies Inc.
|
11,363,498 | $61,362,887 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
332,300 | $43,777,199 | |
| 5 | VTRS |
Viatris Inc
|
2,907,645 | $39,282,278 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
59,152 | $35,075,949 | |
| 7 | HLN |
Haleon plc
|
3,063,916 | $30,669,795 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
963,824 | $29,030,375 |
All Filings in ZTS
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $233,380,104 | 1,974,284 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $12,045,599 | 101,900 | Put | Defined | 2026-05-15 | |
| 2025-12-31 | $205,677,697 | 1,634,698 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $8,429,940 | 67,000 | Put | Sole | 2026-02-17 | |
| 2025-09-30 | $359,400,544 | 2,456,264 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $449,655,930 | 2,883,334 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $535,042,189 | 3,249,573 | Shares | Defined | 2025-11-21 | |
| 2024-12-31 | $560,136,228 | 3,437,895 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $600,608,275 | 3,074,052 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $520,176,036 | 3,000,554 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $518,671,792 | 3,065,255 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $595,824,891 | 3,018,822 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $526,553,595 | 3,026,518 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $505,402,764 | 2,934,805 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $542,339,239 | 3,258,467 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $487,395,251 | 3,325,795 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $498,626,749 | 3,362,511 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $570,524,217 | 3,319,124 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $649,831,910 | 3,445,739 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,003,271,014 | 4,111,261 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $762,675,102 | 3,928,480 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $760,211,818 | 4,079,265 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $622,172,294 | 3,950,802 | Shares | Defined | 2021-07-20 | |
| 2021-03-31 | $2,362,200 | 15,000 | Call | Defined | 2021-07-20 | |
| 2020-12-31 | $608,730,346 | 3,678,129 | Shares | Defined | 2021-02-16 | |
| 2020-12-31 | $2,482,500 | 15,000 | Call | Defined | 2021-02-16 | |
| 2020-09-30 | $570,120,344 | 3,447,544 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $414,157,212 | 3,022,163 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $369,373,472 | 3,138,529 | Shares | Defined | 2020-06-16 | |
| No filing history on record for this holder in this stock. | ||||||